We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
In a landmark ruling, a Californian court has found that a brand name manufacturer of a drug could be held liable for medical complications that occur from a generic equivalent, if they are found to have inadequately labelled the original product.